Ernest Sampias has served as a director on our board of directors since May 1, 2004. He wasappointed as the Chief Financial Officer for Local Matters, Inc. in Denver, Colorado as of June, 2005.Mr. Sampias has over 25 years of related experience in financial management roles. Prior to joiningLocal Matters, Inc., Mr. Sampias was the Chief Financial Officer for McDATA. He also has 15 years ofexperience in several financial management positions with US West. Mr. Sampias’ last assignment forUS West was as Vice President and Chief Financial Officer for US West DEX, which was the YellowPages Directory subsidiary of US West with annual revenues of $1.6 billion. Mr. Sampias also hasfinancial management experience with Convergent Communications, Inc., Aerojet-General Corporation,and Nimbus, Inc. Mr. Sampias graduated from Indiana University with a Bachelors of Science degreein Business with distinction. Mr. Sampias holds a Masters degree in Taxation from DePaul University inChicago. Mr. Sampias is a Certified Public Accountant and a member of the Financial ExecutivesInternational organization.Steve Sanghi has served as a director on our board of directors since May 1, 2004. Mr. Sanghicurrently serves as Director and President of Microchip Technology, Inc. since his appointment inAugust 1990, as CEO since October 1991, and as chairman of the board of directors sinceOctober 1993. Mr. Sanghi was previously the chairman of the board of Adflex Solutions, and a memberof the board of directors of both Artisoft and Vivid Semiconductor. Mr. Sanghi worked for IntelCorporation from 1978 to 1988 in various engineering and management positions, including GeneralManager of Intel’s programmable memory operation. Mr. Sanghi received a Bachelor of Science inElectronics and Electrical Communications Engineering from Punjab Engineering College in India in1975 and holds a Masters degree in Electrical and Computer Engineering from the University ofMassachusetts in Amherst, Massachusetts.Our directors may be reached at the address of our San Jose facility in the United States or at ourheadquarters in Havant in the United Kingdom.Item 6B: CompensationDirector CompensationWe paid our board of directors (consisting of 6 persons) an aggregate amount of $816,000 for thefiscal year ending November 30, 2005 (of which $659,000 comprised salaries or fees, $20,000 comprisednon-cash payments and $137,000 comprised bonus payments). In addition, during our fiscal year endedNovember 30, 2005, we have also awarded four members of our board of directors options to purchase115,000 <strong>Xyratex</strong> Ltd common shares at $14.31 per share granted for no consideration.Our Compensation Committee, composed entirely of independent directors, determines theremuneration of our directors. We also reimburse directors for reasonable expenses incurred inattending meetings of the board, meetings of committees of the board and our general meetings. Nocompensation, save reasonable expenses incurred, will be paid to executive directors in respect of theirrole as a director.Executive CompensationThe aggregate compensation paid to the seven executive officers of <strong>Xyratex</strong> Ltd for the fiscal yearending November 30, 2005 was $2,138,000 (of which $1,336,000 comprised salary, $93,000 comprisednon-cash payments and $709,000 comprised bonus payments). In addition, during our fiscal year endedNovember 30, 2005, we have also awarded five executive officers options to purchase 240,000<strong>Xyratex</strong> Ltd common shares at $14.31 per share granted for no consideration.At the end of our 2005 fiscal year, bonus amounts to be paid to respective executive officers weredetermined on a discretionary basis by the board of directors based on the satisfaction of certain64
performance criteria by the individual executive officer. Non-cash payments to executive officersconsisted of leased cars and health insurance.Item 6C: Board PracticesBoard PracticesOur board of directors currently consists of six members of which a majority are independentdirectors. All directors hold office until their successors have been elected and qualified or until theirearlier death, resignation, disqualification or removal. The terms of office of the directors is dividedinto three classes:• Class I, whose term will expire at the annual general meeting to be held in 2007;• Class II, whose term will expire at the annual general meeting to be held in 2006; and• Class III, whose term will expire at the annual general meeting to be held in 2008.Class I consists of Andrew Sukawaty and Ernest Sampias; Class II consists of Steve Barber andJonathan Brooks; and Class III consists of Steve Sanghi and Nic Humphries. At each annual generalmeeting after the initial classification or special meeting in lieu thereof, the successors to directorswhose terms expire will then serve from the time of election until the third annual meeting followingelection or special meeting held in lieu thereof. In addition, a resolution of the board of directors maychange the authorized number of directors within the upper and lower limits set out in our bye-laws.Any additional directorships resulting from an increase in the number of directors will be distributedamong the three classes so that, as nearly as possible, each class will consist of one-third of thedirectors. This classification of the board of directors may have the effect of delaying or preventingchanges in control or management of our company.The employment contracts governing the service of our directors do not provide for benefits upontermination of employment. There are no family relationships among any of our directors, executiveofficers or key employees.Board CommitteesOur bye-laws give our board of directors the authority to delegate its powers to a committeeappointed by the board. Committees may consist partly or entirely of non-directors, except for the auditcommittee, nominations and governance committee and compensation committee, which must consistonly of independent directors. Our committees are required to conduct meetings and take action inaccordance with the directions of the board and the provisions of our bye-laws or the written chartersestablishing these committees.Compensation CommitteeOur Compensation Committee consists of Andrew Sukawaty, Jonathan Brooks and Steve Sanghi,each of whom satisfy the ‘‘independence’’ requirements of the Nasdaq Corporate Governance Rules.The Compensation Committee determines the remuneration policy as well as the terms and conditionsof service and the cessation of service of our directors and executive officers, and evaluates thecompensation plans, policies and programs of the Company to encourage high performance, promoteaccountability and insure that employee interests are aligned with the interests of the Company’sshareholders. Members of the Compensation Committee do not participate in decisions regarding theirown remuneration. The Compensation Committee generally meets at least four times a year and met6 times during the financial year ended November 30, 2005. Its members are not eligible for bonuses orpension entitlements. The committee has access to the services of independent advisors as it requires.65
- Page 3:
XYRATEX LTDANNUAL REPORT FOR THE YE
- Page 6 and 7:
INTRODUCTIONWe are incorporated und
- Page 8 and 9:
Year Ended November 30,2005 2004 20
- Page 10 and 11:
The computations for the weighted a
- Page 12 and 13:
The markets in which we operate are
- Page 14 and 15:
technological capabilities. This co
- Page 16 and 17:
may cease production of components,
- Page 18 and 19: • potentially adverse tax consequ
- Page 20 and 21: We could incur substantial costs, i
- Page 22 and 23: influence by voting at a meeting of
- Page 24 and 25: Xyratex Ltd to the former sharehold
- Page 26 and 27: In addition to the rapid growth of
- Page 28 and 29: RAID controller technology is proje
- Page 30 and 31: Our Competitive StrengthsDisk drive
- Page 32 and 33: the storage subsystem and disk driv
- Page 34 and 35: Our storage subsystems are internal
- Page 36 and 37: systems are capable of testing a fu
- Page 38 and 39: Research and DevelopmentWe have ove
- Page 40 and 41: • sets forth procedures for the p
- Page 42 and 43: Item 4C: Organization StructureXyra
- Page 44 and 45: ecame the parent company of our bus
- Page 46 and 47: Foreign Exchange Rate FluctuationsT
- Page 48 and 49: we recorded in the year ended Novem
- Page 50 and 51: Fiscal Year Ended November 30, 2005
- Page 52 and 53: Research and Development—otherThe
- Page 54 and 55: Fiscal Year Ended November 30, 2004
- Page 56 and 57: Selling, General and Administrative
- Page 58 and 59: Quarterly Results of OperationsThe
- Page 60 and 61: sales growth. The increase in defer
- Page 62 and 63: choose to make or alliances we have
- Page 64 and 65: compete. Identifiable intangible as
- Page 66 and 67: ITEM 6: DIRECTORS, SENIOR MANAGEMEN
- Page 70 and 71: Audit CommitteeOur Audit Committee
- Page 72 and 73: Employee Benefit/Share Option Plans
- Page 74 and 75: The maximum amount that any partici
- Page 76 and 77: Restricted StockRestricted stock aw
- Page 78 and 79: the options, warrants or rights, bu
- Page 80 and 81: Quarterly high and low market price
- Page 82 and 83: whose functional currency is not th
- Page 84 and 85: on the Nasdaq National Market and,
- Page 86 and 87: Interest RatesWe had cash and cash
- Page 88 and 89: aggregate in any fiscal year and th
- Page 90 and 91: (This page has been left blank inte
- Page 92 and 93: XYRATEX LTDAUDITED CONSOLIDATED BAL
- Page 94 and 95: F-4XYRATEX LTDAUDITED CONSOLIDATED
- Page 96 and 97: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 98 and 99: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 100 and 101: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 102 and 103: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 104 and 105: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 106 and 107: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 108 and 109: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 110 and 111: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 112 and 113: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 114 and 115: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 116 and 117: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 118 and 119:
XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 120 and 121:
XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 122 and 123:
XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 124 and 125:
XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 126 and 127:
XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 128 and 129:
XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 130:
(This page has been left blank inte